Ana Gonzalez-Lopez - Publications

Recommendations from the Spanish Society of Medical Oncology to advance the humanization in cancer care.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: July 09, 2026

Pneumonitis and Sacituzumab Govitecan: A Case of Metastatic Triple-Negative Breast Cancer.

Journal: Archivos de bronconeumologia

Published: November 16, 2025

Efficacy of anti-PD1 therapy in PD1-high mRNA tumors across multiple cancer types: results from cohort 1 and cohort 2 of the phase II SOLTI-1904 ACROPOLI trial.

Journal: ESMO open

Published: June 16, 2025

Challenging Endocrine Sensitivity of Hormone Receptor-Positive/HER2-Negative Advanced Breast Cancer with the Combination of Eribulin and Endocrine Therapy: The REVERT Study.

Journal: Cancers

Published: November 08, 2022

Relationship between Aldehyde Dehydrogenase, PD-L1 and Tumor-Infiltrating Lymphocytes with Pathologic Response and Survival in Breast Cancer.

Journal: Cancers

Published: August 14, 2022

Oral metronomic vinorelbine combined with endocrine therapy in hormone receptor-positive HER2-negative breast cancer: SOLTI-1501 VENTANA window of opportunity trial.

Journal: Breast cancer research : BCR

Published: February 16, 2019

Fatty acid intake and breast cancer in the Spanish multicase-control study on cancer (MCC-Spain).

Journal: European journal of nutrition

Published: November 26, 2018

Experience with eribulin in HR+/HER2- metastatic breast cancer, including a male.

Journal: Future oncology (London, England)

Published: April 04, 2018

Safety of eribulin as third-line chemotherapy in HER2-negative, advanced breast cancer pre-treated with taxanes and anthracycline: OnSITE study.

Journal: The breast journal

Published: November 24, 2017